Literature DB >> 15542398

Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.

D A Chistiakov1, K V Savost'anov, R I Turakulov.   

Abstract

Graves' disease (GD) is a complex autoimmune thyroid disorder with a strong genetic component. Genome-wide screens resolved several susceptibility loci that contribute to the development of GD. One of the susceptibility loci (GD-1 locus) was mapped on chromosome 14q31. However, a susceptibility gene located within the GD-1 locus remains undefined. Here we screen eighteen single nucleotide polymorphisms (SNPs), each is situated at a corresponding positional candidate gene, located within the GD-1 susceptibility locus on chromosome 14q23-q32, for predisposition to GD using the transmission disequilibrium test in 126 simplex Russian families affected with GD. Among SNPs tested, a significant preferential transmission of the Ala allele (41 transmissions vs. 17 nontransmissions, corrected P=0.031) of the Thr92Ala SNP within the DIO2 gene, encoding type II iodothyronine deiodinase, from parents to affected children was found in a Russian family data set. The Thr92Ala SNP of the DIO2 gene and the D727E substitution of the thyrotropin receptor (TSHR) gene have been found to be in pair-wise linkage disequilibrium. The A92/E727 haplotype showed significant preferential transmission from parents to affected sibling (17 transmissions vs. 8 nontransmissions, P=0.039) in simplex families. This suggests that the Thr92Ala variant of the DIO2 gene is associated or may be in linkage disequilibrium with a functional DIO2 polymorphism which involves in the development of GD in a Russian population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542398     DOI: 10.1016/j.ymgme.2004.07.011

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

Review 1.  Factors affecting statistical power in the detection of genetic association.

Authors:  Derek Gordon; Stephen J Finch
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

3.  Tourette disorder spectrum maps to chromosome 14q31.1 in an Italian kindred.

Authors:  Guido J Breedveld; Giovanni Fabbrini; Ben A Oostra; Alfredo Berardelli; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2010-05-02       Impact factor: 2.660

4.  Association of Type II 5' Monodeiodinase Thr92Ala Single Nucleotide Gene Polymorphism and Circulating Thyroid Hormones Among Type 2 Diabetes Mellitus Patients.

Authors:  Dhanunjaya Yalakanti; Pragna B Dolia
Journal:  Indian J Clin Biochem       Date:  2015-08-13

5.  Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population.

Authors:  Bushra Shahida; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2018-07-20

6.  Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions.

Authors:  Oliver J Brand; Stephen C L Gough
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

7.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

8.  Enhancement of soluble CD28 levels in the serum of Graves' disease.

Authors:  Zhongwen Sun; Lixian Yi; Hong Tao; Jingfang Huang; Zhenghong Jin; Yang Xiao; Caiyun Feng; Jing Sun
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

9.  Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population-A preliminary study.

Authors:  Natalia Wawrusiewicz-Kurylonek; Olga Martyna Koper-Lenkiewicz; Joanna Gościk; Janusz Myśliwiec; Przemysław Pawłowski; Adam Jacek Krętowski
Journal:  Mol Genet Genomic Med       Date:  2019-04-01       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.